
Prolific Machines raises $55m in Series B1 funding to shine light on optogenetics’ potential in biotech
Biomanufacturing technology provider Prolific Machines raised $55 million in Series B1 funding, which will go to support the commercialization of its light-based biotech platform, company Co-founder and CEO Deniz Kent told FoodNavigator-USA.



